Paine Schwartz completed an investment in Elemental Enzymes.

Paine Schwartz, a private equity firm, completed an investment in Elemental Enzymes, a biotechnology research company. Financial terms were not disclosed. "We are excited about this investment from Paine Schwartz, which marks the next phase in our effort to build the world's leading supplier of sustainable agricultural inputs. The Paine Schwartz team brings significant expertise and resources that will help us across our business including launching new products, expanding our technical and R&D capabilities, and entering new markets and segments. We look forward to working closely with them to build on our strong foundation and capture new growth opportunities by addressing some of the most complex issues in agriculture head-on," Brian Thompson, Elemental Enzymes Co-Founder and CEO.